Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Royalty Pharma plc (Nasdaq: RPRX) today announced that it has entered into an agreement with Biogen to provide research and development (R&D) funding of up ...

Biogen faces revenue challenges as Leqembi sales lag projections. Investors watch its pipeline expansion and strategic moves amid upcoming Q4 earnings.

European Union regulators will review new information relating to the safety of Eisai Co.’s and Biogen Inc.’s medicine for Alzheimer’s disease, providing a response after a meeting next month.

Biogen (BIIB) and Eisai announced an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as treatment for early AD, or mild cognitive impairment due to ...

Bio Capital Group, the UK’s largest producer of green energy using food waste, has acquired the High Hedley Biogas plant near Durham. Located near Durham, the site has been acquired from WJ Drennan ...

True as that might be, paying with data or ads (instead of blocking ads) is usually a win-win scenario in my eyes. This won’t be everyone’s view, but as a millennial, I remember the days when ...

Nope, there’s nothing wrong with your TV—that was an ad you just saw on Amazon Prime Video. Like many of the big streaming services, Amazon Prime Video has rolled out an ad-supported tier ...

Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the March 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay ...

A £20m anaerobic digestion (AD) plant planned for the outskirts of Southwold will be smell-free and will result in just a small increase in traffic movements, residents were told at a meeting ...